The future of sovereign immunity deals after Allergan ruling

01-03-2018

The future of sovereign immunity deals after Allergan ruling

tumsasedgars / iStockphoto.com

Late last week, the Patent Trial and Appeal Board (PTAB) rejected a Native American tribe’s attempt to dismiss inter partes reviews (IPRs) based on the tribe’s sovereign immunity claims.


generics, Restasis, patent invalidation, Allergan, Saint Regis Mohawk Tribe, PTAB, IPR, sovereign immunity


LSIPR